https://www.hcplive.com/view/low-dose-atropine-eye-drops-reduce-myopia-progression-children
Results from the phase 3 CHAMP trial may support low-dose atropine as a pharmacological treatment option for myopia progression in children.
Create an account or login to join the discussion